Popular Articles

Prevalence Of Artemisinin Monotherapies Raising Risk Of Resistence
Almost half of all artemisinin manufacturers and malaria-endemic countries are "failing to comply" with WHO requirements to sell the treatment in combination with other drugs, which is increasing the risk that malaria parasites will develop resistance to artemsinin, Nature reports. "Of the 69 manufacturers of artemisinin monotherapies that the WHO has identified, 21 have withdrawn monotherapies, and 14 say they intend to comply with the WHO"s recommendations. But the remaining 34 have not yet disclosed their intentions," Nature writes.
generic viagra online
Why Do Indians Suffer Heart Failure?
Over 3,400 South Asians have taken part in the UK"s largest study into heart failure in ethnic minority populations. Researchers at the University of Birmingham in the UK have been carrying out the study, involving members of the Indian community. Patients, who are registered with GPs in the Birmingham area of the English Midlands, were screened at their local surgery, to discover how common, heart failure is among them.
News of the day
BioElectronics Announces Pivotal Clinical Study On Musculoskeletal Disorders
BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced its sponsorship of a groundbreaking clinical study on musculoskeletal disorders. The randomized, double blinded and placebo-controlled study will be supervised by a primary investigator, Sheena Kong, MD of San Francisco, California in conjunction with several other leading physicians.
Mental Health

Fresenius Endorses PEAK Campaign Efforts To Reduce Dialysis Patient Mortality

Fresenius Medical Care, which operates the nation"s leading network of dialysis clinics, today endorsed the Performance Excellence and Accountability in Kidney Care (PEAK) campaign recently launched by Kidney Care Partners (KCP) - a coalition of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with chronic kidney disease (CKD). The PEAK initiative is designed to significantly reduce the mortality rate for patients in their first year of dialysis. "The PEAK initiative is consistent with our ongoing commitment to improving the quality of care," said Dr. J. Michael Lazarus, Fresenius Medical Care"s chief medical officer. "Fresenius Medical Care has always emphasized quality of care in our facilities, and one area of concern has been the increased risk of death in the first year after starting dialysis treatment. Through our RightStart™ program, we were able to demonstrate that a structured program of prompt medical and educational strategies focused on patients in their first three months on dialysis does improve morbidity and mortality rates. So while we know that high mortality rates are a significant problem, we also know that if the entire kidney care community works together toward a common goal, we can make progress in this critical area." Many factors contribute to first-year mortality among dialysis patients. Individuals starting dialysis face complex challenges, such as control of anemia, dietary changes, and vascular access management. They must also adjust to a demanding regular treatment schedule. During this transition period, patients are most susceptible to complications. PEAK is a quality improvement campaign that seeks to mitigate these challenges, pledging to extend, even save, as many as 10,000 lives and reduce mortality among first-year dialysis patients by 20 percent by the end of 2012. "Improvements in quality of care have been at the top of the kidney care community"s agenda over the past 15 years. Significant progress has been made, but the PEAK initiative raises the bar for the next 10 years," said Lazarus. "It says to patients, their families, and everyone concerned with kidney disease that there is a concrete effort in place to address real problems with actual solutions, using recommendations from leading researchers and experts. At a critical time in their lives, when the risks are greatest, dialysis patients and their families can be confident that the PEAK initiative is contributing to improving the chances for survival and a better life for all dialysis patients." Fresenius Medical Care North America


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):